Daiichi-Sankyo Korea chief to head KPMA’s special committee
Published: 2013-06-13 06:58:00
Updated: 2013-06-13 06:58:00
The special committee for Japanese drug firms in Korea, under the umbrella of the Korea Pharmaceutical Manufacturers Association (KPMA), said Tuesday that it appointed Kim Dae-joong, chief executive of Daiichi-Sankyo Korea, as its new chair.
With its eight member companies, the committee will ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
